Endothelin-1 and Norepinephrine Overflow from Cardiac Sympathetic Nerve Endings in Myocardial Ischemia
Open Access
- 25 June 2012
- journal article
- review article
- Published by Hindawi Limited in Cardiology Research and Practice
- Vol. 2012, 1-7
Abstract
In protracted myocardial ischemia, sympathetic activation with carrier-mediated excessive norepinephrine (NE) release from its nerve endings due to reversal of NE transporter in an outward direction is a prominent cause of arrhythmias and cardiac dysfunction. Endothelin-1 (ET-1) and its receptors are intimately involved in the regulation of this carrier-mediated NE overflow in protracted myocardial ischemia. The ET-1 system is often complex, sometimes involving opposing actions depending on which receptor subtype is activated, which cells are affected, and whether stimuli are endogenously generated or exogenously applied. Therefore, a detailed understanding of the ET-1 system is important for applying drugs acting on this system in clinical settings for the treatment of ischemic cardiac disease. This article provides a detailed analysis of how the ET-1 system is involved in the regulation of carrier-mediated NE release from sympathetic nerve endings in protracted myocardial ischemia.Keywords
This publication has 54 references indexed in Scilit:
- Cardiac myocytes control release of endothelin-1 in coronary vasculatureAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Different Contributions of Endothelin-A and Endothelin-B Receptors in Postischemic Cardiac Dysfunction and Norepinephrine Overflow in Rat HeartsCirculation, 2005
- Acute effects of 17β-estradiol on myocardial pH, Na+, and Ca2+ and ischemia-reperfusion injuryAmerican Journal of Physiology-Cell Physiology, 2005
- Nitric Oxide Protects Cardiac Sarcolemmal Membrane Enzyme Function and Ion Active Transport against Ischemia-induced InactivationJournal of Biological Chemistry, 2003
- Tezosentan in patients with acuteheart failure and acute coronary syndromesJACC, 2003
- Cardioprotection by long-term ETA receptor blockade and ACE inhibition in rats with congestive heart failure: mono- versus combination therapyCardiovascular Research, 2002
- A Live-Cell Assay for Studying Extracellular and Intracellular Endothelin-Converting Enzyme ActivityHypertension, 1997
- Increased plasma level of endothelin-1-like immunoreactivity during coronary spasm in patients with coronary spastic anginaThe American Journal of Cardiology, 1991
- Conversion of Big Endothelin-1 to 21-Residue Endothelin-1 Is Essential for Expression of Full Vasoconstrictor ActivityJournal of Cardiovascular Pharmacology, 1989
- A possible role of noradrenaline in the development of myocardial infarctionAmerican Heart Journal, 1978